Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Clinical Transplantation|November 19, 2024
The Impact of Statin Intensity on the Early Progression of Cardiac Allograft VasculopathyXinyi Huang, Melana Yuzefpolskaya, Paolo C Colombo, et al.
Pharmacotherapy|December 16, 2020
Immunosuppression considerations in simultaneous organ transplantDanielle Kovac, Jason Choe, Esther Liu, et al.
Clinical Transplantation|August 8, 2024
Contemporary Immunosuppression Management and 1-Year Outcomes in Dual Organ Heart TransplantationXinyi Huang, David Salerno, Danielle Kovac, et al.
Heart Failure Reviews|June 10, 2022
PCSK9 inhibitors safely and effectively lower LDL after heart transplantation: a systematic review and meta-analysisDouglas L Jennings, Lina Sultan, Jennifer Mingov, et al.
Clinical Transplantation|July 18, 2024
Cardio-Renal-Metabolic Outcomes Associated With the Use of GLP-1 Receptor Agonists After Heart TransplantationElena M Donald, Elissa Driggin, Jason Choe, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 20, 2021
Guiding therapeutic plasma exchange for antibody-mediated rejection treatment in lung transplant recipients - a retrospective studyOlga A Timofeeva, Jason Choe, Mohamed Alsammak, et al.
Clinical Transplantation|September 10, 2022
Letermovir for cytomegalovirus prophylaxis in high-risk heart transplant recipientsStephanie Golob, Jaya Batra, Ersilia M DeFilippis, et al.
Clinical Transplantation|March 20, 2024
Utility of a fusion protein T-cell co-stimulation blocker Belatacept in heart transplant recipients: Real world experience from a high volume centerDaniel Oren, Matan Uriel, Cathrine M Moeller, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 30, 2025
Efficacy and safety of belatacept in heart transplant recipientsJulia Baranowska, Daniel Oren, Andrea Fernandez Valledor, et al.
Journal of Cardiac Failure|June 25, 2025
Efficacy of Letermovir for Cytomegalovirus Prophylaxis in Heart Transplant Recipients with Moderate to High-Risk CMV SerostatusAfsana Rahman, Changhee Lee, Salwa Rahman, et al.
Pageof 1